Image

Transcriptomic Responses for the Identification of Pathogens

Transcriptomic Responses for the Identification of Pathogens

Recruiting
2-45 years
All
Phase N/A

Powered by AI

Overview

Acute undifferentiated febrile infection (AUFI) is a common presenting syndrome in low-resource settings and better diagnostics are urgently needed to improve patient management and guide disease prevention interventions. Assessment of the host gene expression response to infection in endemic populations has demonstrated significant promise as a new approach to identifying patients with enteric fever and for potential in differentiating between other causes of AUFI. Signatures identified through new data analytic techniques could be developed into a point-of-care test for use in endemic settings.

In this multisite diagnostic evaluation study we will collect prospective clinical, laboratory and diagnostic data from two endemic settings to evaluate host gene expression signatures for detecting enteric fever and for determining the cause of AUFI in LMIC settings.

Eligibility

FEBRILE ADULTS- INCLUSION CRITERIA

  • Age greater than or equal to 15 years and less than or equal to 45 years
  • Participant is willing and they and/or an appropriate guardian/relative/representative is able to give informed consent for participation in the study and a follow-up (telephone) discussion at 14 days
  • Febrile illness without localising features (see 'exclusion criteria' and 'screening' sections) where fever is defined as:
    • documented tympanic/rectal temperature of ≥ 38°C or an axillary/oral temperature of ≥ 37.8°C and
    • Reported duration of fever 3-14 days
  • They may have had recent exposure to antimicrobials.

FEBRILE ADULTS- EXCLUSION CRITERIA

  • The participant may not enter the study if ANY of the following apply:
  • Unable to provide informed consent and no next of kin is willing and able to provide informed consent.
  • Any history or clinical suspicion of:
    • Rheumatological or connective tissue disorder (e.g. Rheumatoid arthritis)
    • Autoimmune condition (e.g. Autoimmune Hepatitis)
    • Malignancy
    • Active treatment with immunomodulating medications, or for tuberculosis (pulmonary or extrapulmonary) or any other chronic infection.
  • Pregnancy (breast feeding mothers will NOT be excluded)
  • Hospitalisation within 4 weeks prior to current admission
  • Vaccination within 4 weeks prior to current admission
  • They live outside of the normal/local catchment area for each hospital site
  • Localising signs or symptoms of infection sufficient to diagnose the likely cause of acute febrile illness and thus prevent it from being 'undifferentiated' (see Section 8.4 'Screening and Eligibility').

CONTROLS- INCLUSION CRITERIA

  • Participant is willing and they are (and in 15-18 year olds, a guardian is) able to give informed consent for participation in the study
  • Age greater than or equal to 15 years and less than or equal to 45 years
  • They live outside of the normal/local catchment area for each hospital site
  • Afebrile (as defined by no reported fever and temperature ≤ 38°C or an axillary/oral temperature of ≤ 37.8°C).

CONTROLS- EXCLUSION CRITERIA

  • The participant may not enter the study if ANY of the following apply:
  • Unable to provide informed consent and no next of kin (or parent/guardian in the case of a minor) is willing and able to provide informed consent.
  • Current treatment for or prior history, or clinical suspicion of:
    • Rheumatological or connective tissue disorder
    • Autoimmune condition
    • Malignancy
    • Active treatment for tuberculosis (pulmonary or extrapulmonary) or clinical suspicion of active tuberculosis. Previous completed treatment is not a reason for exclusion.
    • Active treatment with immunomodulating medications or any other chronic infection.
  • Pregnant (breast feeding mothers will NOT be excluded)
  • Hospitalisation within 4 weeks of recruitment
  • Vaccination within 4 weeks prior to recruitment
  • Antimicrobial use within 4 weeks of recruitment
  • They live outside of the normal/local catchment area for each hospital site
  • Participant reports feeling more unwell than usual on the day of enrolment.

EXPLORATORY AIMS- PAEDIATRIC CRITERIA; INCLUSION CRITERIA

  • Age greater than or equal to 2 years and less than 15 years
  • As above for adult participants.

EXPLORATORY AIMS- PAEDIATRIC CRITERIA; EXCLUSION CRITERIA

  • Parent/guardian is unwilling, and/or patient aged 8 to 14 years is unwilling to assent to provide informed consent.
  • As above for adult participants.

Study details
    Enteric Fever
    Acute Febrile Illness
    Typhoid
    Paratyphoid Fever
    Fever

NCT04878549

University of Sheffield

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.